tiprankstipranks
Design Therapeutics (DSGN)
NASDAQ:DSGN
US Market
DSGN
Design Therapeutics
RESEARCH TOOLSreports
Want to see DSGN full AI Analyst Report?

Design Therapeutics (DSGN) Income Statement

100 Followers

Design Therapeutics Income Statement

Last quarter (Q1 2026), Design Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Design Therapeutics's net income was $-17.64M. See Design Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -622.00K$ -596.00K$ -537.00K$ -466.00K$ 0.00
Operating Expenses
$ 78.84M$ 61.79M$ 77.65M$ 67.13M$ 35.83M
Depreciation and Amortization
$ 622.00K$ 596.00K$ 537.00K$ 466.00K$ 129.00K
EBITDA
$ -78.84M$ -48.99M$ -66.33M$ -62.84M$ -35.70M
Operating Income
$ -79.47M$ -62.38M$ -78.19M$ -67.59M$ -35.83M
Other Income/Expenses
$ 9.68M$ 12.79M$ 11.33M$ 4.29M$ 298.00K
Pretax Income
$ -69.79M$ -49.59M$ -66.86M$ -63.31M$ -35.53M
Net Income
$ -69.79M$ -49.59M$ -66.86M$ -63.31M$ -35.53M
Per Share Metrics
Basic EPS
$ -1.22$ -0.88$ -1.19$ -1.14$ -0.77
Diluted EPS
$ -1.22$ -0.88$ -1.19$ -1.14$ -0.77
Weighted Average Shares Outstanding
 57.33M 56.59M 55.98M 55.71M 45.94M
Weighted Average Shares Outstanding (Diluted)
 57.33M 56.59M 55.98M 55.71M 45.94M
Currency in USD

Design Therapeutics Earnings and Revenue History